Hadassah

Hadassah Physician Receives Hebrew University Award for Research on New Type 1 Diabetes Treatment

Thursday, Jun 14 2012

For her research on a new treatment for Type 1 diabetes, a Hadassah University Medical Center physician has received the Kaye Innovation Award from the Hebrew University. The treatment is now undergoing commercial development.

Dr. Chamutal Gur, a senior physician in Hadassah's Internal Medicine Department, as well as a Ph.D. student under the supervision of Prof. Ofer Mandelboim of the Institute for Medical Research Israel-Canada at the Hebrew University Faculty of Medicine, won the award for her research on the role of Natural Killer cells in autoimmune diseases. Her main project focuses on the function of the NKp46 killer receptor in Type 1 diabetes (T1D).

In people with T1D, autoreactive T cells attack the pancreatic beta cells, which produce natural insulin in the body. Natural Killer (NK) cells, which are part of our innate immune system, kill hazardous cells by using an array of cell receptors. One of the most potent is the NKp46 and Dr. Gur found that it specifically recognizes pancreatic beta cells, which leads to it destroying them.

Dr. Gur, in collaboration with other researchers at Hadassah and Ben-Gurion University, identified this phenomenon in both animal and human cell tests, demonstrating the importance of the NKp46 receptor in the development of diabetes. Concurrently, the research highlights the therapeutic potential of an anti-NKp46 monoclonal antibody (mAb) as a new treatment for T1D. Monoclonal cells are produced from a single ancestral cell by repeated cellular replication and, therefore, can be said to form a single "clone."

Based on the results, a patent was filed through the Hebrew University's Yissum Technology Transfer Company; Hadasit, the commercial arm of Hadassah; and BGN Technologies, the technology transfer company of Ben-Gurion University. The technology was licensed to BioLineRx to develop a blocking anti-NKp46 mAb for the treatment of T1D.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Tuesday, Jun 20 2017

Send in the Clowns: A Hadassah UK Dispatch

This week Hadassah UK (HUK) brought in one of the Hadassah Medical Organization's best and more unusual, head medical clown David Barashi (DuSH).

READ MORE ›
alt_text

Friday, Jun 16 2017

Hadassah’s Director General Receives Honorary PhD from Cyprus Medical School

For sharing his knowledge and experience with senior officials in the Cyprus medical system, Prof. Zeev Rotstein, Director General of the Hadassah Medical Organization, was awarded an honorary PhD from the St. George University of London’s Medical Program at the University of Nicosia Medical School in Cyprus.

READ MORE ›
alt_text

Thursday, Jun 8 2017

Hadassah Doctors Discover Bullet
in 12-Year-Old’s Arm

Muhammad Baduan, age 12, had been experiencing pain in his arm on and off for months. Hadassah Hospital Ein Kerem Emergency Room physicians put an end to the boy’s pain when they solved the mystery: Muhammad had a 22-millimeter bullet hidden in that arm--a bullet that had been shot into the air as part of a post-wedding ceremony celebration.

READ MORE ›
alt_text

Monday, Jun 5 2017

Hadassah Cutting-Edge Neuropsychiatrist Keynotes Alzheimer’s Conference

“The key is to give medicines much earlier--before the brain material has been destroyed by Alzheimer’s disease,” Dr. Shahar Arzy, head of the Hadassah Medical Organization’s Computational Neuropsychiatry Laboratory, told his audience at the Alzheimer’s Foundation of America (AFA)’s New York Educational Conference on May 5, 2017.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More